Product NDC: | 45963-327 |
Proprietary Name: | PHENDIMETRAZINE TARTRATE |
Non Proprietary Name: | Phendimetrazine Tartrate |
Active Ingredient(s): | 35 mg/1 & nbsp; Phendimetrazine Tartrate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45963-327 |
Labeler Name: | Actavis, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040762 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121120 |
Package NDC: | 45963-327-11 |
Package Description: | 100 TABLET in 1 BOTTLE (45963-327-11) |
NDC Code | 45963-327-11 |
Proprietary Name | PHENDIMETRAZINE TARTRATE |
Package Description | 100 TABLET in 1 BOTTLE (45963-327-11) |
Product NDC | 45963-327 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Phendimetrazine Tartrate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20121120 |
Marketing Category Name | ANDA |
Labeler Name | Actavis, Inc. |
Substance Name | PHENDIMETRAZINE TARTRATE |
Strength Number | 35 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC] |